Product Assessment

Expanding Into Asia-Pacific: Life sciences opportunities and strategies for success
Objective :

Analysis of Cyclophosphamide products in development in Oncology space along with periodic Assessment of development of API competitors to provide understating of API product landscape relating to cyclophosphamide development and launch.

Problem Statement:

A large pharma client was working to develop their cyclophosphamide API and FD and was interested to assess competitive products in the same domain and area to provide benchmarking of their asset in comparison to their competitors The client requested periodic reports (Quarterly) on the developmental milestones of competitor companies, thorough assessment of the competitor products through Secondary and Primary CI inputs.

Our Methodology:
  • Conference Assessment
  • Company Assessment
  • R&D development Assessment
  • FD Formulation Assessment
  • Primary Assessment
  • Analysis
  • Periodic Insight Generation
Results:

DelveInsight provided effective quarterly reports to track developmental, regulatory & commercial milestones of competitor products.

XX Company (Summary Findings)
  • XX has the API for this product
  • XX doesn’t have the FD
  • XX is in direct business with most of the European and US customers and also through distributors/agents for API
YY Company (Summary Findings)
  • The product is available in the market.
  • Providing bulk capacity will not be possible
  • Capacity constraint problems have arisen, creating production backlogs in Eastern Europe and Latin American market.

Related Insights

Out-Licensing Opportunity
Out-Licensing Opportunity

A Small Pharmaceutical Client Based At Sweden, Europe With Capabilities Around A Neonatal Mesenchymal Cells Involved DelveInsight [...]

View Case
Due Diligence
Due Diligence

A medium pharmaceutical client with capabilities in novel formulations was involved in a deal with a manufacturing company for commercial-scale manufacturing of the client’s therapies. [...]

View Case
Pipeline Assessment
Pipeline Assessment

A medium pharmaceutical client based in the United States with capabilities in cancer immunotherapy domain involved DelveInsight to analyze current pipeline activity of T-Cell Receptor (TCR) products for cancer treatment. [...]

View Case

Fill the form to download the case study

I consent to DelveInsight gathering details provided via this form. Check our Privacy Policy to know more.